Flood Law Group, LLP Sponsors CrestorCardiomyopathyLawyer.com
CrestorCardiomyopathyLawyer.com aims to provide information about the possible risks of Crestor®. Flood Law Group, LLP, a litigation firm, is sponsoring CrestorCardiomyopathyLawyer.com, an online resource that intends to provide people with information about the potential risks of Crestor®. According to Flood Law Group, LLP, patients who are diagnosed with cardiomyopathy and who were treated with Crestor® might be eligible for compensation.
(PRWEB) August 29, 2011
Cardiomyopathy is a serious condition in which the heart muscle deteriorates. Crestor® and other statin medications have been shown to lower levels of Coenzyme Q10 (CoQ10).
Ã¢Å“Statins block the endogenous biosynthesis of both cholesterol and CoQ10 by inhibiting the enzyme HMG CoA reductase, thus decreasing mevalonate, the precursor of both cholesterol and CoQ10,Ã¢ Peter H. Langsjoen, M.D., F.A.C.C. wrote in the study, The Clinical use of HMG CoA-reductase inhibiters (statins) and the associated depletion of the essential co-factor enzyme Q10.
CoQ10 is important for heart function as it provides the heart with the energy it needs to pump blood efficiently. Patients with low levels of CoQ10 are at an increased risk of heart problems such as cardiomyopathy.
Cardiomyopathy is a disease of the heart muscle. Symptoms can include difficulty breathing, swelling of the legs, ankles and feet, rapid heartbeats, tiredness, dizziness, lightheadedness and fainting.
CrestorCardiomyopathyLawyer.com is an online resource that aims to provide individuals and families with information about the possible risk of cardiomyopathy associated to Crestor® .
For more information, please call 1-800-889-3898.
# # #
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebcrestor/cardiomyopathy/prweb8755118.htm